- Miniaturize electrochemical systems in the detection of an anticancer agents interaction with DNA2008 | Faculty of Science
- Supramolecular approach for target transport of photodynamic anticancer agents2012 | First Faculty of Medicine
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Inhibitors of microtubules2001 | Faculty of Science
- Inhibitors of microtubules2001 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Development of an LC-MS/MS method for analysis of interconvertible Z/E isomers of the novel anticancer agent, Bp4eT2010 | Central Library of Charles University
- Ferns and Lycopods - A Potential Treasury of Anticancer Agents but Also a Carcinogenic Hazard2014 | Faculty of Medicine in Hradec Králové
- Interaction of a Potential Anticancer Agent Hypericin and its Model Compound Emodin with DNA and Bovine Serum Albumin2018 | First Faculty of Medicine
- Development of HPLC method for determination of a novel anticancer agent - Dp44mT - in rabbit plasmaPublication without faculty affiliation
- Potential anticancer agent hypericin and its model compound emodin: interaction with DNA2016 | First Faculty of Medicine
- 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Faculty of Medicine in Hradec Králové
- Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro2018 | Faculty of Science
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, Faculty of Physical Education and Sport, First Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Second Faculty of Medicine
- Sawhorse-type diruthenium tetracarbonyl complexes containing porphyrin-derived ligands as highly selective photosensitizers for female reproductive cancer cells2009 | Faculty of Science
- Investigation of vanadocene(IV) alpha-amino acid complexes: Synthesis, structure, and behavior in physiological solutions, human plasma, and blood2006 | Faculty of Science
- The interaction of antitumor active vanadocene dichloride with sulfur-containing amino acids2007 | Faculty of Science
- Water-soluble arene ruthenium complexes containing pyridinethiolato ligands: Synthesis, molecular structure, redox properties and anticancer activity of the cations [(eta(6)-arene)Ru(p-SC5H4NH)(3)](2+)2008 | Faculty of Science
- Targeting mitochondria for cancer treatment2012 | First Faculty of Medicine
- Anticancer chemotherapeutics ellipticines: molecular mechanisms of theri action2001 | Faculty of Science
- Anticancer chemotherapeutics ellipticines: molecular mechanisms of theri action2001 | First Faculty of Medicine, Faculty of Mathematics and Physics
- HPMA copolymers with hydrazone-attached doxorubicin are efficient in the treatment of mouse T cell lymphoma EL4Publication without faculty affiliation
- Pharmaceutical chemistry IV2006 | Faculty of Pharmacy in Hradec Králové
- Cardiotoxicity of cancer therapy2011 | First Faculty of Medicine
- ABL1, SRC and other non-receptor tyrosine-kinases as new targets for specific anticancer therapy2010 | First Faculty of Medicine
- Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT22019 | Faculty of Science
- Mitochondria-targeted compounds in the treatment of cancer2020 | Third Faculty of Medicine
- Evaluation of respiration of mitochondria in cancer cells exposed to mitochondria-targeted agents2015 | Faculty of Science
- Immunotherapy for prostate cancer2016 | Second Faculty of Medicine
